Dr. Tirado is interested in developing medication treatments for drug addiction, applying chronic disease paradigms to the treatment of addiction, educating healthcare professionals on the science of addiction and improving access to evidence based practices for the treatment of addiction. Currently principle investigator of a NIDA funded survey of adolescent heroin addiction. Currently consultant on a Robert Wood Johnson Foundation grant for implementation of medication assisted treatment for addiction.
RESEARCH INTERESTS
Medication treatment of addiction
Clinical and translational research on addiction
Treatment of addiction in minorities
RECENT PUBLICATIONS
Tirado CF, Goldman M, Lynch K, Kampman KM, O?Brien CP, "Atomoxetine for marijuana dependence: a report on the efficacy and high incidence of GI adverse events in a pilot trial" Drug and Alcohol Dependence, Volume 94(1-3):pp 254-257, April 2008
Kyle M Kampman, Helen M Pettinati, Kevin G Lynch, TomWhittingham, Wayne Macfadden, Charles Dackis, Carlos Tirado, David W Oslin, Thorne Sparkman, Charles P O’Brien, "A double-blind, placebo-controlled pilot trial of quetiapine for treatment of Type A and Type B alcoholism" Journal of Clinical Psychopharmacology, 27(4):344-351, August 2007
Kampman, K.M., Dackis, C., Lynch, K.G., Pettinati, H.M., Tirado, C., Gariti, P., Sparkman, T., Atzram, M., O’Brien, C.P, "A double-blind, placebo-controlled trial of amantadine and propranolol for the treatment of cocaine dependent patients with severe cocaine withdrawal symptoms" Drug and Alcohol Dependence, 85(2):129-137, 2006
Point and right click (click and hold for Mac users) your mouse onand select "Save this link (or target) as..." option to save the file to your local computer.
and select "Save this link (or target) as..." option to save the file to your local computer.